View Clinical Trial (Medical Research Study)
Interferon Alfa Sensitivity in HIV/HCV Coinfected Persons Before and After Antiretroviral Therapy
| City: |
|
Baltimore |
| State: |
|
Maryland |
| Zip Code: |
|
21287 |
| Conditions: |
|
HIV Infection - Hepatitis C |
| Purpose: |
|
The chief purpose of this research is to evaluate interferon alpha sensitivity and cell type
specific levels of interferon receptor and interferon stimulated genes and proteins in HIV/
HCV (hepatitis C virus) coinfected persons before and after administration of HIV
medications (antiretroviral therapy).
|
| Study Summary: |
|
We plan to perform liver biopsy by microlaparoscopy on previously untreated HIV/HCV
coinfected persons, then give them a dose of peginterferon alfa 2b. HCV and HIV kinetics
will be studied. Afterward, HIV will be treated using antiretroviral therapy and the
procedure will be repeated.
|
| Criteria: |
|
Inclusion Criteria:
- Adult Human
- Able to provide written informed consent
- HIV antibody positive
- HIV viral load positive
- HIV treatment naive
- Hepatitis C antibody positive
- Hepatitis C viral load positive
- Hepatitis C treatment naive
- Approved to take HIV medications for minimum 9 months
- Willing to use contraception, Life expectancy greater than 2 years
Exclusion Criteria:
- Significant opportunistic infections within 12 month
- Hepatitis B positive
- Evidence of liver cirrhosis
- Decompensated liver disease
- Chronic alcohol abuse
- Allergy to raltegravir, tenofovir, and/or emtricitabine
- Active or suspected malignancy
- Sarcoidosis
- Active TB
- Coronary artery disease
- Uncontrolled seizures
- Untreated thyroid disease
- Untreated diabetes
- Weight greater than 125 kg
- Severe depression or severe psychiatric disorder
- Ongoing alcohol or illicit drug use
- Pregnant, nursing, pr planning to become pregnant
- Allergy to interferon
|
| NCT ID: |
|
NCT01285050 |
| Primary Contact: |
|
Rosie Silva Phone: 410-502-7134 Email: rsilva6@jhmi.edu
|
| Backup Contact: |
|
N/A |
| Location Contact: |
|
Baltimore, Maryland 21287 United States
Rosie Silva Phone: 410-502-7134 Email: rsilva6@jhmi.edu
Site Status: Recruiting |
| Data Source: |
|
ClinicalTrials.gov |
| Date Processed: |
|
May 23, 2013 |
| Modifications to this listing: |
|
Only selected fields are shown, please use the link
below to view all information about this clinical trial. |
|
Click to view Full Listing
|